Future Science Group Journals ‘Read & Publish’ Transitional Agreement 2021-2022

  • Start: 1 Jan 2021
    Expiry: 31 Dec 2022
  • Description:

    A Read & Publish transitional agreement for Future Science Group's 20 hybrid and 15 Open Access journals, including read access and unlimited open access publishing for all articles.

Product overview

Future Science Group publishes 35 STM journals across three imprints: Future Medicine Ltd, Future Science Ltd and Newlands Press Ltd. Journals cover basic and clinical areas of biomedicine, and the portfolio includes titles such as BioTechniques, Future Oncology, Nanomedicine, Epigenomics, Immunotherapy, Bioanalysis, and Regenerative Medicine.

This product offers read access to 20 hybrid journals along with immediate open access publishing in these titles and FSG's 15 fully open access titles for ALL authors at participating institutions, for all article types, for a fixed fee.

Update Type

Information not available.

Update Notes

Information not available.